| scholarly article | Q13442814 |
| P2093 | author name string | B. J. Mondino | |
| S. I. Brown | |||
| P2860 | cites work | Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19 | Q33650055 |
| Autoimmune Phenomena of the External Eye | Q40959623 | ||
| Prospects in the management of tear-deficiency states | Q44783969 | ||
| Autoimmune phenomena in ocular cicatricial pemphigoid | Q44794099 | ||
| Immunofluorescent Studies of Ocular Cicatricial Pemphigoid | Q46331880 | ||
| HLA Antigens in Ocular Cicatricial Pemphigoid | Q66892610 | ||
| Induced ocular pseudopemphigoid | Q67487055 | ||
| Benign mucous membrane pemphigoid. 1. Secretion of mucus and tears | Q70018203 | ||
| Ocular cicatricial pemphigoid | Q70149761 | ||
| T and B lymphocytes in ocular cicatricial pemphigoid | Q70186637 | ||
| Immunosuppressive therapy for progressive ocular cicatricial pemphigoid | Q70249115 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ophthalmology | Q161437 |
| cicatricial pemphigoid | Q627291 | ||
| P304 | page(s) | 453-459 | |
| P577 | publication date | 1983-10-01 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | Immunosuppressive therapy in ocular cicatricial pemphigoid | |
| Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid | |||
| P478 | volume | 96 |
| Q36237529 | Autoimmune bullous diseases: ocular manifestations and management |
| Q72241402 | Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics |
| Q40827033 | B- and T-lymphocytes in Ocular Disease |
| Q77314346 | Chronic cicatrizing conjunctivitis in a patient with ocular cicatricial pemphigoid and fatal Wegener granulomatosis |
| Q40773560 | Chronic progressive conjunctival cicatrisation |
| Q37945609 | Cicatricial pemphigoid and erythema multiforme |
| Q37308498 | Cryotherapy for trichiasis in ocular cicatricial pemphigoid |
| Q33517496 | Cyclophosphamide for ocular inflammatory diseases |
| Q37297613 | Dapsone therapy for the acute inflammatory phase of ocular pemphigoid |
| Q42521669 | Drug-induced cicatricial pemphigoid affecting the conjunctiva. Light and electron microscopic features |
| Q35304020 | Eosinophil granule proteins expressed in ocular cicatricial pemphigoid |
| Q35215156 | Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom |
| Q34436707 | Eye involvement in autoimmune blistering diseases |
| Q33920749 | Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. |
| Q72849994 | Hard-palate mucosa graft in Stevens-Johnson syndrome |
| Q69368774 | Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a T cell-mediated disease |
| Q73211528 | Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid |
| Q24250186 | Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita |
| Q54071658 | Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. |
| Q37324313 | Local interferon alfa-2b for ocular cicatricial pemphigoid |
| Q72924052 | Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid. Implications for patient selection and surgical considerations |
| Q67483292 | Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid |
| Q77144024 | Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction |
| Q40480334 | Management of the immunobullous disorders. I. Pemphigoid |
| Q49833864 | Mucous membrane pemphigoid |
| Q77161223 | Mucous membrane pemphigoid |
| Q46661473 | Mucous membrane pemphigoid with ocular involvement. Part II: therapy |
| Q36168693 | Ocular cicatricial pemphigoid: manifestations and management |
| Q37319447 | Progression of disease in ocular cicatricial pemphigoid |
| Q67935476 | Remission and Recurrence after Withdrawal of Therapy for Ocular Cicatricial Pemphigoid |
| Q68097362 | Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid |
| Q57220852 | Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid |
| Q37311216 | Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid |
| Q77902757 | Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid |
| Q37321480 | Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid |
| Q39096598 | The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. |
| Q43842999 | The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid |
| Q34436725 | Treatment of subepidermal immunobullous diseases |
| Q41359384 | Treatment strategies in mucous membrane pemphigoid |
| Q36071599 | Upper and lower conjunctival fornix depth in healthy white caucasian eyes: a method of objective assessment. |
| Q34996874 | Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis |
Search more.